A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma.
about
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future TherapiesTrial Watch: Adoptive cell transfer for oncological indicationsTrial watch: Dendritic cell-based anticancer therapyRationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy.Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer VaccinationSingle vs. combination immunotherapeutic strategies for glioma.A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma.Glioma-derived extracellular vesicles selectively suppress immune responses.Adjuvant-Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination.ANTI-TUMOR IMMUNE RESPONSES INDUCED BY RADIOTHERAPY: A REVIEW.Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells.The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer ImmunotherapiesIdentification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma.Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12-13 May 2017.Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials.Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, December 5th 2015.Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment.Phase 1/2 study of immunotherapy with dendritic cells pulsed with autologous tumor lysate in patients with refractory bone and soft tissue sarcoma.Trial watch: Dendritic cell-based anticancer immunotherapy.Self-Delivering RNAi Targeting PD-1 Improves Tumor-Specific T Cell Functionality for Adoptive Cell Therapy of Malignant MelanomaAntitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination
P2860
Q26752558-3CF04138-6DF2-4CA1-8D1D-521A83A6BC57Q26785545-CBF8AEFA-A768-4060-9B1C-7440DABD6D9BQ27024047-C45C97B3-90D2-404F-B695-A11D7B744007Q27686800-4C063E15-BE61-487C-BDD3-62EF1EC5E9D1Q28068378-761315D4-7FEC-4591-901F-E1BF3C2D1CBFQ33746041-8ADA9D5D-2478-4F14-ADD0-7B97DAECCF3BQ36562370-4BBD7CD2-5C45-4A49-85AF-CB7F83824F43Q36705896-5EB7F6E2-29E5-472E-9D62-1EF98B97A1CFQ37357786-7389A466-2C5B-4A36-A234-B9A55E643252Q38541959-2E26BD9A-A947-4F3F-82A3-23514707D6C3Q38672403-D6656AC2-EB42-4A48-B838-9183F0BA6B7AQ39079690-AE7E83B8-CAA7-4D54-8ABB-B1482BD85C25Q41442041-93FCF1B8-EDBE-4D92-82B9-A2EC4FDD4C31Q42078847-636096B8-9D73-494A-9F7C-A2DF4B0679F3Q42336210-AFE67752-C592-40F7-BE6E-35A16334B8D9Q42925679-25E7F927-9F2F-4298-92DF-E18FF50DE03FQ43147493-7E1BD0F7-0B7E-4A75-9779-877396E8F07BQ47130393-C1D534A6-9CDB-43FC-B485-F319CC6AFBB5Q49835172-FF863898-BD08-4B9A-B3C9-C762067EFE82Q51120716-A5477C8A-4C14-406C-9C96-01CBFD8521A8Q53109846-1C6DE245-831C-4D9E-8B2D-47CFBE6C2368Q56891950-9C091FBE-C647-4DE5-97DA-641DE04BE77CQ58742957-469512D5-72B0-4199-AD77-4933D441A874
P2860
A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A phase I clinical trial combi ...... tients with stage IV melanoma.
@en
A phase I clinical trial combi ...... tients with stage IV melanoma.
@nl
type
label
A phase I clinical trial combi ...... tients with stage IV melanoma.
@en
A phase I clinical trial combi ...... tients with stage IV melanoma.
@nl
prefLabel
A phase I clinical trial combi ...... tients with stage IV melanoma.
@en
A phase I clinical trial combi ...... tients with stage IV melanoma.
@nl
P2093
P2860
P1476
A phase I clinical trial combi ...... atients with stage IV melanoma
@en
P2093
Emilia Andersson
Isabel Poschke
Johan Hansson
Lars Adamson
Maria Nyström
Roger Tell
Rolf Kiessling
P2860
P2888
P304
P356
10.1007/S00262-014-1575-2
P577
2014-07-04T00:00:00Z